Drug – bio-affecting and body treating compositions – Identification or warning feature – Taste or smell or chemical irritation to the eye – nose – or...
Patent
1988-02-16
1990-07-24
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Identification or warning feature
Taste or smell or chemical irritation to the eye, nose, or...
514657, 514872, 514922, A61K 2700, A61K 31135
Patent
active
049434284
ABSTRACT:
A method for the alleviation of both motion sickness and chemically-induced emesis is provided which includes the administration of a nontoxic, therapeutically effective amount of a composition which stimulates serotonin-1A receptors in a mammal in need of such treatment. The preferred compounds for use are buspirone and 8-hydroxy-2(di-n-propylamino)-tetralin (8-OH-DPAT).
REFERENCES:
patent: 3930022 (1975-12-01), Hauck et al.
patent: 4076843 (1978-02-01), Hauck et al.
patent: 4087545 (1978-05-01), Archer et al.
patent: 4101677 (1978-07-01), Dunnigan et al.
patent: 4163063 (1979-07-01), Cannon et al.
patent: 4228169 (1980-10-01), Johnson et al.
patent: 4410519 (1983-10-01), Seiler et al.
patent: 4486428 (1984-12-01), Eggler et al.
patent: 4620002 (1986-10-01), Sandefur et al.
patent: 4680404 (1987-07-01), Eggler et al.
patent: 4721720 (1988-01-01), Wootton et al.
patent: 4722933 (1988-02-01), Horn
patent: 4749718 (1988-06-01), Coates et al.
patent: 4753789 (1988-06-01), Tyers et al.
Saelens, David A., Ph. D., "Antiemetic Drugs," M.U.S.C. School of Pharmacy Lecture Series, 1976, pp. 1-5.
Mansbach et al., "Discriminative Stimulus Properties of Buspirone in the Pigeon", J. Pharmacol. Exp. Ther., Feb. 1987, 240(2), pp. 364-369 (Abstract).
Goodman et al., The Pharmacological Basis of Therapeutics, 7th Ed (1985), pp. 633-634.
Colino et al., Chem. Abst. 106(1): 536m.
Marsden et al. Chem. Abst. 106(3): 12851y.
Allen et al., "Pharmacologic Effects of MJ9022-1, a Potential Tranquilizing Agent," Arzneim-Forsch, vol. 24(6), pp. 917-922 (1974).
James B. Lucot, "Blockade of 5-Hydroxytryptamine.sub.3 Receptors Prevents Cisplatin-Induced but not Motion-or Xylazine-Induced Emesis in the Cat," Pharmacology Biochemistry & Behavior, vol. 32, pp. 207-210.
Oskenberg et al., "Antagonism of 5-Hydroxytryptamine.sub.1A (5-HT.sub.1A) Receptor-Mediated Modulation of Adenylate Cyclase Activity by Pindolol and Propranolol Isomers," Biochemical Pharmacology, vol. 37, No. 18, pp. 3429-3433, 1988.
Arvidsson et al., "8-Hydroxy-2-(alkylamino)tetralins and Related Compounds as Central 5-Hydroxytryptamine Receptor Agonists", J. Med. Chem., 1984, 27, 45-51.
"Communications to the Editor", Journal of Medicinal Chemistry, 1981, 24, 921-923.
Kennett et al., "Antidepressant-Like Action of 5-HT1A Agonists and Conventional Antidepressants in an Animal Model of Depression", European Journal of Pharmacology, vol. 134, pp. 265-274 (abstract).
Tricklebank et al., "Medication of the Discriminative Stimulus Properties of 8-Hydroxy-2-(di-N-propylamino) Tetralin (8-OH-DPAT) by the Putative 5-HT1A Receptor," European Journal of Pharmacology, vol. 133, pp. 47-56 (abstract).
Crampton George H.
Lucot James B.
Friedman Stanley J.
Wright State University
LandOfFree
Stimulation of serotonin-1A receptors in mammals to alleviate mo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stimulation of serotonin-1A receptors in mammals to alleviate mo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulation of serotonin-1A receptors in mammals to alleviate mo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1266946